Parkwalk closes Arvia follow-on investmentArvia represents a dramatic change from the traditional methods for treating organic liquid waste.
Arvia has established a process for the destruction of radioactive liquid organic wastes produced in the course of nuclear power generation, decommissioning and at stages within the nuclear fuel cycle. The patented technology has been specifically developed for the demands of the nuclear industry. Treatment of the liquid organic waste stream takes place in a single unit with no moving parts, is chemical free and the process can destroy a wide range of radioactive organic waste streams.
Parkwalk closes follow-on investment in OxyntixOxyntix is developing and commercialising new technologies in energy and process engineering.
The technology has numerous applications, notably in nuclear fusion power generation and in sonochemistry, among others, by developing a new method of achieving extreme intensity bubble collapse.
State-of-the-art experimental and computational facilities allow Oxyntix to generate and test innovative ideas and to transform them into practically applicable processes.
Parkwalk closes Clean Air Power Syndicate investmentClean Air Power has pioneered the move towards using natural gas to power vehicles by developing Dual-Fuel™ technologies that guarantee diesel engine performance, with significant cost savings and low carbon emissions.
Minimal changes are required to the existing diesel engine and by burning up to 90% natural gas, customers benefit from a combination of low emissions and high efficiency.
Parkwalk closes investment in AQDOT for the University of Cambridge Enterprise Fund IAQDOT‘s technology allows for an energy- and raw material-efficient way of manufacturing microcapsules, leading to lower energy consumption and less waste.
Potential applications include encapsulating enzymes in laundry detergents, or encapsulating fertilisers in the agrochemical sector. Microencapsulation is a multi-billion-per-annum industry with established applications in household and personal care, food and agrochemical markets.
Parkwalk closes investment in Cambridge CMOS Sensors for the UK Tech Fund IV & University of Cambridge Enterprise Fund IICambridge CMOS Sensors is the provider of innovative MEMS high temperature microhotplate technology for gas sensing, flow sensing and lab-on-a-chip applications.
The Cambridge CMOS Sensors technology uses standard CMOS processes that enable high volume, low cost and low power sensor-on-chip solutions.
Parkwalk closes investment in Cloud Sustainability for the UK Tech Fund IV & ZeroND FundCloud Sustainability is a cloud based software platform that changes the way sustainability knowledge, consultancy and training is delivered.
It reduces costs, educates and empowers the user, creating self-sufficiency and delivering long-term sustainable benefit.
Cloud Sustainability's range of software tools and interactive e-learning resources help build in-house knowledge and skills in all aspects of sustainability and make lasting improvements to clients.
Parkwalk closes investment in Symetrica for the UK Tech Fund IV & ZeroND FundSymetrica specializes in the detection and identification of radioisotopes for Security Applications.
The company works with prime contractors and government agencies to design, develop, test and deploy detection equipment for use by law enforcement personnel, customs officers, the emergency services, military personnel and first responders.
Parkwalk closes Omega Diagnostic plc investmentOmega Diagnostics is focused on selling a wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease.
The company aims to improve human health and well being through innovative diagnostic tests and global partnerships.
Parkwalk closes investment in Microsaic Systems plc for the UK Tech Fund IV & ZeroND FundMicrosaic is the first, and only company to have successfully miniaturised mass spectrometry through the development of its patented chip-based technologies. These technologies are based on Micro-Electrical-Mechanical Systems (MEMS) developed by the Optical and Semiconductor Devices Group at Imperial College.
The Company's first product, the Microsaic 3500 MiD®, was launched in January 2011 and is the world's smallest MS system.
Parkwalk closes investment in Horizon Discovery for the University of Cambridge Enterprise Fund IHorizon's basic science and translational research knowledge deployed in combination with best-in-class translational genomics platforms, products and services provides meaningful solutions to the challenges of translational researchers.
Horizon aspires to provide solutions that unlock the promise of the human genome project for the benefit of scientific researchers, patients and society; provide powerful research tools to advance the development of personalized medicines; provide molecular reference standards and support better healthcare outcomes for patients.
Parkwalk closes investment in Tangentix for the UK Tech Fund III & ZeroND FundTangentix is dedicated to providing the best possible game delivery experience, using proprietary and patented technologies to compress game assets so a typical AAA title is reduced to around 1/3rd of its existing size- making downloads comfortable for nearly all internet users.
This approach means that downloads can reach a wider audience, gamers can buy more games, and publishers benefit from deeper links to the customer and stronger margins.
Parkwalk closes further investment in Xeros on successful £10m raiseXeros' mission is to convert the $100bn global laundry industry to Xeros polymer bead cleaning.
Up to 80% less water, 50% less energy and 50% less detergent is used in the Xeros system versus conventional washing.
If all UK households were fitted with machines powered by Xeros technology, the potential annual savings to UK consumers would be £2bn and would reduce CO2 emissions by 4.2m tonnes - the equivalent of taking 1.4m cars off UK roads.
The technology was launched commercially in late 2012 with successful affirmation sites in London & the US.
Parkwalk closes Sphere Fluidics investment for the University of Cambridge Enterprise Fund ISphere Fluidics has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services.
A novel technology platform (called Cyto-MineTM) enables ultra-high throughput analysis of single cells and generation of their genetic, transcriptomic and proteomic profiles in miniaturised (pl to nl) volumes called picodroplets.
Parkwalk closes OxfordPV follow-on investmentOxfordPV has developed a new solar cell technology that is manufactured from inexpensive, abundant, non-toxic and non-corrosive organic materials and can be scaled to any volume.
The technology replaces the liquid electrolyte with a solid organic semiconductor, enabling entire solar modules to be screen printed onto glass or other surfaces.
Parkwalk closes Oxford YASA Motors investmentYASA Motors is a dynamic and innovative electric motor company bringing a new generation of high power and high torque density electric motors to market.
The Company has developed class leading axial flux traction motors for use in both Automotive (EV's & HEV's) and also Industrial applications